Cogentin and Levothyroxine sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cogentin (benztropine mesylate) and Levothyroxine sodium (levothyroxine sodium). Common drug interactions include psychotic disorder among females and aggression among males.

The phase IV clinical study analyzes what interactions people have when they take Cogentin and Levothyroxine sodium. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.

What is Cogentin?

Cogentin has active ingredients of benztropine mesylate. It is often used in tardive dyskinesia. eHealthMe is studying from 7,692 Cogentin users. Check the latest studies of Cogentin.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,812 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.



On Jul, 05, 2026

96 people who take Cogentin and Levothyroxine sodium together, and have interactions are studied.

Cogentin and Levothyroxine sodium drug interactions.

What are the common drug interactions of Cogentin and Levothyroxine Sodium, by gender? *:

female:

  1. Psychotic disorder
  2. Agitation (state of anxiety or nervous excitement)
  3. Blood triglycerides increased
  4. Diarrhoea
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Insomnia (sleeplessness)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Urinary tract infection
  9. Abnormal behaviour
  10. Aggression

male:

  1. Aggression
  2. Abdominal pain
  3. Hyperglycaemia (high blood sugar)
  4. Hyperlipidaemia (presence of excess lipids in the blood)
  5. Leukocytosis (increased white blood cells)
  6. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  7. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  8. Renal failure (kidney dysfunction)
  9. Vision blurred
  10. Blood glucose increased

What are the common drug interactions of Cogentin and Levothyroxine Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Disease complication
  2. Megacolon (a very dilated colon)

20-29:

  1. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  2. Abdominal pain
  3. Bradycardia (abnormally slow heart action)
  4. Cerebral infarction (less blood supply to brain resulting tissue damage)
  5. Dyspepsia (indigestion)
  6. Encephalopathy (functioning of the brain is affected by some agent or condition)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Hyperglycaemia (high blood sugar)
  9. Hyperlipidaemia (presence of excess lipids in the blood)
  10. Leukocytosis (increased white blood cells)

30-39:

  1. Ill-defined disorder
  2. Type 2 diabetes mellitus
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Depression
  5. Suicide attempt
  6. Blood pressure increased
  7. Death
  8. Fatigue (feeling of tiredness)
  9. Heart rate increased

40-49:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Psychotic disorder
  3. Type 2 diabetes mellitus
  4. Aggression
  5. Agitation (state of anxiety or nervous excitement)
  6. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  7. Anxiety
  8. Confusion
  9. Dizziness (excl vertigo)
  10. Dyspnoea exertional (breathlessness or shortness of breath)

50-59:

  1. Confusional state
  2. Depressed level of consciousness
  3. Depression
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Drug administration error
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Dystonia (abnormal muscle tone)
  8. Erythema (redness of the skin)
  9. Haematocrit decreased
  10. Haemoglobin decreased

60+:

  1. Leukopenia (less number of white blood cells in blood)
  2. Psychotic disorder
  3. Erythema (redness of the skin)
  4. Fall
  5. Hypertension (high blood pressure)
  6. Lymphocyte count increased
  7. Platelet count decreased
  8. Small intestinal obstruction (blockage in small intestine)
  9. Stress
  10. Abdominal pain

What are the existing conditions these people have? *

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 15 people, 15.62%
  2. Pain: 12 people, 12.50%
  3. Psychotic Disorder: 9 people, 9.38%
  4. Depression: 9 people, 9.38%
  5. Stress And Anxiety: 8 people, 8.33%
  6. Bipolar Disorder (mood disorder): 8 people, 8.33%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 7.29%
  8. Parkinson's Disease: 6 people, 6.25%
  9. Insomnia (sleeplessness): 6 people, 6.25%
  10. Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 5.21%

* Approximation only. Some reports may have incomplete information.

Do you take Cogentin and Levothyroxine sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cogentin and Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cogentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cogentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levothyroxine sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on benztropine mesylate and levothyroxine sodium (the active ingredients of Cogentin and Levothyroxine sodium, respectively), and Cogentin and Levothyroxine sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: